Bioclinica, a global life sciences services provider that uses technology to bring clarity to clinical trials, has expanded and enhanced its SMART technology suite by making it available with medical imaging, electronic data capture (EDC) and interactive response technology (IRT) combined with all essential activities in a common data set. Investigative sites can now access medical imaging, EDC and IRT data via a single, easy-to-use portal and can view, analyse and act on data. Implementation is underway by a major pharmaceutical company and a leading CRO using Bioclinica’s enhanced SMART technology for their global trial portfolio.
Additional benefits of the enhanced SMART technology suite include real-time data reconciliation, automation, reduced data management effort and faster database lock. It allows sites to skip these data-cleaning steps since information is automatically and continuously updated and scrubbed. This prevents downstream errors that can potentially affect data quality and compliance. The system acts as a prototype patient screening, enrolment and dispensing system within days of protocol receipt and allows plug-in functionality with Bioclinica Site & Patient Payments, Cardiac Safety (ECG and ABPM), and Clinical Event Adjudication, as well as being compatible with data supply from third-party providers.
For further information about Bioclinica and its SMART technology suite visit www.bioclinica.com
Latest from Tom Mulligan
- Concept Life Sciences forms Scientific Advisory Board
- Sangamo finalises TxCell acquisition
- Polyplus-transfection introduces new nanoparticle DNA transfection reagent
- The 6th SGS Biopharma Day Seminar: a new early-phase clinical trials paradigm
- Blacktrace expands its presence in Japan with new office in Kanagawa
- MaSTherCell doubles production capacity
- Absolute Antibody expands production facilities
- Optibrium and University of Nottingham collaborate on innovative teaching programme
- Diamond Pharma Services wins both Futures and Support categories at TOPRA Awards
- Droplet microfluidics offers new approach for studying plant cell biomechanics